HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Cécile Ged Selected Research

Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)

11/2013Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.
7/2012Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors.
8/2010Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation.
6/2008[Successful gene therapy of mice with congenital erythropoietic porphyria].
1/2008Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Cécile Ged Research Topics

Disease

7Erythropoietic Porphyria (Congenital Erythropoietic Porphyria)
11/2013 - 02/2005
3Iron Overload
09/2014 - 04/2005
3Porphyrias
06/2008 - 07/2002
2Colorectal Neoplasms (Colorectal Cancer)
06/2015 - 06/2014
2Hemolytic Anemia
11/2013 - 07/2012
1Thrombophilia
01/2015
1Homocystinuria
01/2015
1Neoplasms (Cancer)
06/2014
1Hemochromatosis (Bronze Diabetes)
05/2012
1Atrophy
12/2011
1Inflammation
12/2011
1Liver Failure
06/2008
1Asthma (Bronchial Asthma)
01/2007
1Infection
01/2007
1Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris)
01/2007
1Atopic Dermatitis (Atopic Eczema)
01/2007
1Erythropoietic Protoporphyria
09/2003
1Hepatitis
01/2003
1Hepatoerythropoietic Porphyria
07/2002
1Porphyria Cutanea Tarda
07/2002

Drug/Important Bio-Agent (IBA)

5Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA
11/2013 - 01/2008
5Heme (Haem)IBA
08/2010 - 09/2003
2irinotecan (Camptosar)FDA LinkGeneric
06/2015 - 06/2014
1CystathionineIBA
01/2015
1type 4 HemochromatosisIBA
09/2014
1metal transporting protein 1 (ferroportin)IBA
09/2014
1IronIBA
09/2014
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2013
1Transferrin (beta 2 Transferrin)IBA
05/2012
1IntegrinsIBA
12/2011
1EnzymesIBA
06/2008
1filaggrinIBA
01/2007
1Immunoglobulin E (IgE)IBA
01/2007
1Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA
01/2007
1Alkylating AgentsIBA
01/2007
1Non-alcoholic Fatty Liver DiseaseIBA
04/2005
1Ferrochelatase (Heme Synthetase)IBA
09/2003
1enhanced green fluorescent proteinIBA
01/2003
1Peptide Elongation Factors (Elongation Factor)IBA
01/2003
1Codon (Codons)IBA
07/2002
1Glycine (Aminoacetic Acid)FDA LinkGeneric
07/2002
1PorphyrinsIBA
07/2002
1Glutamic Acid (Glutamate)FDA Link
07/2002

Therapy/Procedure

2Bone Marrow Transplantation (Transplantation, Bone Marrow)
06/2008 - 02/2005
1Liver Transplantation
06/2008
1Stem Cell Transplantation
02/2005